Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
10%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
BBP
65
HOLDINGS
10%
ALSO IN IBRN
IBRN
60
HOLDINGS
15%
ALSO IN BBP
SECTOR DRIFT (BBP minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
ACADIA PHARMACEUTICALS INC | 2.4% | 3.3% | 2.4% |
|
AXSOME THERAPEUTICS, INC. | 2.2% | 3.7% | 2.2% |
|
PTC THERAPEUTICS INC | 2.0% | 4.1% | 2.0% |
|
NEUROCRINE BIOSCIENCES INC | 1.9% | 3.9% | 1.9% |
|
BIOGEN IDEC INC | 1.5% | 3.9% | 1.5% |
BBP Overweight Relative to IBRN
|
INSMED INC | 3.3% |
|
BRIDGEBIO PHARMA, INC. | 3.2% |
|
ALNYLAM PHARMACEUTICALS INC | 3.0% |
|
RHYTHM PHARMACEUTICALS, INC. | 3.0% |
|
MIRUM PHARMACEUTICALS, INC. | 3.0% |
|
BEIGENE LTD. SPONSORED ADR | 2.9% |
|
IONIS PHARMACEUTICALS, INC. | 2.7% |
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
ASCENDIS PHARMA A/S | 2.6% |
|
HALOZYME THERAPEUTICS INC | 2.6% |
BBP Underweight Relative to IBRN
|
SCHOLAR ROCK HOLDING CORP. | -4.9% |
|
SUPERNUS PHARMACEUTICALS INC | -4.1% |
 |
ARGENX SE ADR | -3.8% |
|
CATALYST PHARMACEUTICAL PART | -3.7% |
 |
ALKERMES PLC | -3.7% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.5% |
|
DENALI THERAPEUTICS INC. | -3.0% |
|
SAREPTA THERAPEUTICS INC | -2.7% |
|
DYNE THERAPEUTICS INC | -2.5% |
|
BIOGEN IDEC INC | -2.4% |